AnneFSchottMD

PubMed

• Reply to G.B. Mann et al and S. Sorscher.
  Reshma Jagsi, Kent A Griffith, Eleanor E Harris, Jean L Wright, Abram Recht
  Journal of Clinical Oncology. 2024-06-01
• 17 citations
  Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEA.
  Reshma Jagsi, Kent A Griffith, Eleanor E Harris, Jean L Wright, Abram Recht
  Journal of Clinical Oncology. 2024-02-01
• Investigating potential disparities in clinical trial eligibility and enrollment at an NCI-designated comprehensive cancer center.
  Monica A Patel, Jennifer L Shah, Floyd John Brinley 4th, Paul H Abrahamse, Christine M Veenstra
  Cancer Medicine. 2023-06-01

Journal Articles

• Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors  
  Erin F Cobain, Francis Worden, Scott M Schuetze, Mark M Zalupski, Vaibhav Sahai, Ajjai Alva, Anne F Schott, Moshe Talpaz, JAMA Oncology
• Adjuvant exemestane with ovarian suppression in premenopausal breast cancer  
  Pagani O, Regan MM, Walley BA, Fleming GF, Colleoni M, Lang I, Gomez HL, Tondini C, Burstein HJ, Perez EA, Ciruelos E, Stearns V, Bonnefoi HR, Martino S, Geyer CE Jr, ..., N Engl J Med, 1/1/2014
• Adjuvant ovarian suppression in premenopausal breast cancer  
  Francis PA, Regan MM, Fleming GF, Lang I, Ciruelos E, Bellet M, Bonnefoi HR, Climent MA, Da Prada GA, Burstein HJ, Martino S, Davidson NE, Geyer CE Jr, Walley BA, Cole..., N Engl J Med, 1/1/2014
• A randomized placebo-controlled phase III study of duloxetine for treatment of aromatase inhibitor (AI)-associated musculoskeletal symptoms in women with early-stage b...  
  Henry NL, Unger JM, Schott A, Hansen L, Lew D, Wade JL, Moinpour C, Hortobagyi GN, Meyskens FL, J Clin Oncol, 1/1/2014
• Targeting Intrinsically-Resistant Breast Cancer Stem Cells with Gamma-Secretase Inhibitors  
  Chang J, Landis M, Schott A, Pavlic A, Dobrolecki L, Korkaya H, Zhang X, Froehlich A, Rodriguez A, Rimawi M, Wicha M, Lewis M, Hayes D, Cancer Res, 1/1/2009
• Book Review, 2nd edition, Bland K and Copeland E, editors  
  Schott AF, Oncology, 1/1/2001
• Herceptin: an example of the success of translational research  
  Schott AF and Ethier SP, Michigan Oncology Journal, 1/1/1999
• Leukemia and lymphoma  
  Schott AF, Primary Care Update, 1/1/1997
• Bcl-XL protects cancer cells from p53-mediated apoptosis  
  Schott AF, Apel I J, Nunez G, Clarke M F, Oncogene, 1/1/1995
• Anion Affinity of Carbonylbis (triphenylphosphine Rhodium (I)) in CH2Cl2; Fluoride vs its Halide Analogs  
  Branan DM, Hoffman MW, McElroy EA, Miller NC, Ramage DL, Schott AF, and Young SH, Inorganic Chemistry, 1/1/1987
• Join now to see all

Books/Book Chapters

• Adjuvant Therapy of Cancer VIII 
  Chapter: Section VII: Conference Summary, Adjuvant therapy of cancer VIII: concluding perspectives. 
  Page 289 - 298Schott A and Baker LHEditors: JH Glick, RD Gerber, A Goldhirsch, H-J Senn.Lippincott-Raven Publishers, Philadelphia, PA1997

Abstracts/Posters

• Phase Ib Trial of the Gamma Secretase Inhibitor (GSI), MK-0752 Followed by Docetaxel in Locally Advanced or Metastatic Breast Cancer
  Schott AF, Chang JC, Krop IE, Griffith KA, Layman RM, Hayes DF, Wicha MS, Cancer Res, 1/1/2010

Lectures

• Management of HER-2/neu Overexpressing Breast Cancer 
  Plymouth, MI - 1/1/2014
• New Trends in Breast Cancer Treatment 
  Grand Rapids, MI - 1/1/2014
• Funding Opportunities Offered by SWOG and The Hope Foundation 
  Chicago, IL - 1/1/2014
• Rare Cancer Research in SWOG 
  Chicago, IL - 1/1/2014
• SWOG Membership Opportunities and Benefits 
  Chicago, IL - 1/1/2014
• Management of Estrogen Receptor Positive Metastatic Breast Cancer 
  Thompsonville, MI - 1/1/2014
• Developing the Cancer Therapies of the Future 
  Perdido Beach Resort, Orange Beach, AL - 1/1/2014
• Challenges in Designing Clinical Trials for Stem Cell Directed Therapies, Targeting Cancer Stem Cells 
  San Francisco, CA - 1/1/2014
• Breast Cancer Her2/ER 
  Chicago, IL - 1/1/2012
• Highlights of the Day: Breast Cancer Her2/ER 
  Chicago, IL - 1/1/2012
• Why Does This Cancer Therapy Work in a Petri Dish and Not in my Patient? 
  San Antonio, TX - 1/1/2011
• Simple oral therapy with capecitabine (CAPE) and cyclophosphamide (CPA) for metastastic breast cancer (MBC) 
  Chicago, IL - 1/1/2010
• Adjuvant Systemic Therapy of Breast Cancer 
  Boyne Falls, MI - 1/1/2010
• Approaches to Metastastic Disease in Breast Cancer 
  Dearborn, MI - 1/1/2010
• Controversies in Breast Cancer Treatment 
  Troy, MI - 1/1/2010
• The Angiotensin Receptor and Breast Cancer 
  Chicago, IL - 1/1/2009
• Adjuvant Therapy of Breast Cancer 
  Detroit, MI - 1/1/2009
• Physical and Psychological Consequences of Breast Cancer Diagnosis and Treatment 
  Ann Arbor, MI - 1/1/2009
• When Breast Cancer Treatment Ends: Helping Survivors Stay Healthy 
  New York, NY - 1/1/2008
• Advances in Adjuvant Systemic Therapy 
  Dearborn, MI - 1/1/2008
• Novel Targeted Treatment of Stage IV Breast Cancer 
  Detroit, MI - 1/1/2008
• Updates on Adjuvant Chemotherapy 
  Plymouth, MI - 1/1/2007
• Breast Cancer - Evolving Clinical Practice 
  Ann Arbor, MI - 1/1/2006
• Phase II Endpoints in Cooperative Group Trials 
  Dallas, TX - 1/1/2005
• Adjuvant Chemotherapy for Breast Cancer 
  Dearborn, MI - 1/1/2005
• Join now to see all

Other

• Systemic treatment for HER2-positive metastatic breast cancer. 
  Schott AF, eChapter, UpToDate
  1/1/2017
• Systemic treatment of metastatic breast cancer in women: Chemotherapy 
  Schott AF, eChapter, UpToDate
  1/1/2017
• A case of thigh swelling in a patient with metastatic breast cancer receiving combination chemotherapy. 
  Schott AF, Breast Cancer Online
  1/1/2006
• Recommendations for Comparing Therapeutic Sequences for Patients with Breast, Kidney, and Other Advanced and Metastatic Cancers. 
  Effectiveness Guidance Document Technical Working Group (TWG), Green Park Collaborataive Version
  1/1/2005
• Join now to see all